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Background: In 1957, Tunisia introduced 117 species of Eucalyptus; they have been used as fire wood, for the
production of mine wood and to fight erosion. Actually, Eucalyptus essential oil is traditionally used to treat
respiratory tract disorders such as pharyngitis, bronchitis, and sinusitis. A few investigations were reported on the
biological activities of Eucalyptus oils worldwide. In Tunisia, our previous works conducted in 2010 and 2011 had
been the first reports to study the antibacterial activities against reference strains. At that time it was not possible to
evaluate their antimicrobial activities against clinical bacterial strains and other pathogens such as virus and fungi.
Methods: The essential oils of eight Eucalyptus species harvested from the Jbel Abderrahman, Korbous (North East
Tunisia) and Souinet arboreta (North of Tunisia) were evaluated for their antimicrobial activities by disc diffusion and
microbroth dilution methods against seven bacterial isolates: Haemophilus influenzae, Klebsiella pneumoniae,
Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus agalactiae, Streptococcus pneumoniae and
Streptococcus pyogenes. In addition, the bactericidal, fungicidal and the antiviral activities of the tested oils were
carried out.
Results: Twenty five components were identified by GC/FID and GC/MS. These components were used to correlate
with the biological activities of the tested oils. The chemical principal component analysis identified three groups,
each of them constituted a chemotype. According to the values of zone diameter and percentage of the inhibition
(zdi, % I, respectively), four groups and subgroups of bacterial strains and three groups of fungal strains were
characterized by their sensitivity levels to Eucalyptus oils. The cytotoxic effect and the antiviral activity varied
significantly within Eucalyptus species oils.
Conclusions: E. odorata showed the strongest activity against S. aureus, H. influenzae, S. agalactiae, S. pyogenes,
S. pneumoniae and against all the tested fungal strains. In addition, E. odorata oil showed the most cytotoxic effect.
However, the best antiviral activity appeared with E. bicostata. Virus pretreatment with E. bicostata essential oil
showed better antiviral activity (IC50 = 0.7 mg/ml, SI = 22.8) than cell-pretreatment (IC50 = 4.8 mg/ml, SI = 3.33). The
essential oil of E. astringens showed antiviral activity only when incubated with virus prior to cell infection. This
activity was dose-dependent and the antiviral activity diminished with the decreasing essential oil concentration.
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The Eucalyptus, a native genus from Australia, belongs
to Myrtaceae family and comprises about 900 species
[1]. More than 300 species of this genus contain volatile
oils in their leaves. Fewer than 20, within these species,
known for their high content of 1,8-cineole (more than
70%), have been commercially used for the production
of essential oils in pharmaceutical and cosmetic indus-
tries [2]. Over the past few years, the interest in natural
medicine has been increasing in industrialized societies
particularly against microbial agents because of the ever
growing problem of antibiotic resistance [3]. In Tunisian
folk medicine, inhalation of Eucalyptus sp. essential oil
has traditionally been used to treat respiratory tract dis-
orders such as pharyngitis, bronchitis, and sinusitis [4].
Consequently, the scientific interest in this field has been
expanding. Some researchers have demonstrated some
efficacy of Eucalyptus globulus essential oil against Hae-
mophilus influenzae and Stenotrophomonas maltophilla
[3,5]. Streptococcus pyogenes, Streptococcus pneumoniae,
Streptococcus agalctia, Staphylococcus aureus, Pseudo-
monas aeruginosa, Klebsiella pneumonia and Hemophilis
influenzae are the most important causes of the respira-
tory tract infections and the most resistant to antibiotics.
Many studies reported the antifungal propriety of plant
extracts and essential oils against dermatophytes, filament-
ous and Candida albicans [6,7]. The essential oils extracted
from Eucalyptus species, mainly from E. urophylla S.T.
Blake, E. grandis, E. camaldulensis, E. citriodora and
E. globulus were found to be active on phyto-pathogenic
fungi [8-10].
Few studies have reported the antiviral activity of Euca-
lyptus essential oils against Adenovirus, mumps and
herpes simplex viruses [11,12]. One of the major chal-
lenges is the practical use of these essential oils in vivo.
This is difficult and needs to be overcome by trial assays.
The importance of the antiviral activity of natural com-
pounds is their perspective uses against these pathogens.
Enteroviruses are more prevalent in the environment
than the viruses discussed above and it is worth studying
them for any antiviral activity. To the best of our know-
ledge, there is no published report on the Eucalyptus
essential oils’ activities against human fungal and
enteroviral infections. As reported previously [13,14],
we have studied the antibacterial activity of 35 Eucalyp-
tus essential oils against four reference gastrointestinal
strains (Esherichia coli, ATCC 25922; Pseudomonas aeru-
ginosa, ATCC 227853; Enterococcus faecalis, ATCC
292112; Staphylococcus aureus, ATCC 25932) using the
disc diffusion method. On the basis of the best diameter
inhibition against these pathogens, eight Eucalyptus es-
sential oils were selected and used to evaluate their activ-
ity against bacterial strains isolated from patients




Samples of clean mature leaves of eight species of the
genus Eucalyptus L’HÉR., five of which were collected in
June 2006 from Souiniat arboreta located in the North
west of Tunisia (E. bicostata, E. cinerea, E. maidenii, E.
odorata and E. sideroxylon); two species were collected
in April 2006 from Korbous arboreta (E. astringens and
E. lahmannii); one species was collected from Jbel
abderrahaman arboreta (E. leucoxylon). The last two
arboreta were located in Nabeul region (North East of
Tunisia with sub-humid bioclimatic stage). Botanical
voucher specimens have been deposited in the
Pharmacognosy Laboratory Herbarium in the Faculty
of Pharmacy (Monastir, Tunisia), under the following
references: 0119, 0120, 0126, 0127, 0129, 0132, 0138
and 0154.
Extraction of essential oils
The extraction of essential oils was carried out by hydro-
distillation during four hours, using a standard apparatus
recommended in the European Pharmacopoeia. We
made three attempts for each sample of 100 g of boor-
ishly crushed dried leaves for each species. The oil col-
lected from each plant was then dehydrated with Na2SO4
(Sigma-Aldrich, NY, USA) and stored at 4°C until use.
Chemical analysis
Quantitative and qualitative data for all the essential oils
were performed in triplicate by Gaz Chromatography
(GC) and Gaz Chromatography coupled with the Mass
Spectroscopy (GC/MS), respectively.
Gas chromatography analysis
GC was carried out using Hewlett-Packard (HP) 6890
chromatography apparatus equipped with Flame Ionization
Detector (FID) and Carbowax column (30 m x 0.32 mm
i.d., film thickness 0.25 μm) under the following analyt-
ical conditions: injector and detector temperatures were
maintained at 250°C and 280°C, respectively; oven
temperature programmed to rise from 35°C to 250°C at
5°C/min, isothermal temperature 35°C for 1 min and
250°C for 3 min; the carrier gas was nitrogen with a
flow rate of 1.2 mL/min., the injected volume was 1 μL
sample of 10% solution of oil in purified hexane. Relative
concentrations were calculated using the software HP
Chemstation, which allows the assimilation of the per-
centages of the peak areas to the percentages of the vari-
ous constituents. Retention indices were obtained by
running a series of aliphatic hydrocarbons (C9 - C28) by
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GC column).
Gas chromatography-mass-spectrometry analysis
The chemical analysis of the essential oils was carried
out using a HP 5890 series II gas chromatography ap-
paratus equipped with a polar column Carbowax
(30 m x 0.32 mm i.d., film thickness 0.25 μm) and
5972 mass selective detectors. Helium was used as the
carrier gas. The mass spectrometer operating condi-
tions were: ionisation voltage, 70 eV, ion source 230°C.
The GC/MS parameters were identical to those for the
GC analysis.
Compound identification
The identification of the compounds was based on the
comparison of their retention index (determined rela-
tively to the retention time of aliphatic hydrocarbons
(C9 - C28) and of the mass spectra with those of authen-
tic compounds by means of NBS75K.L. and Wiley 275
databases and with the literature data) [15].
Antibacterial testing
Bacterial strains
The bacterial strains used in the present study were
seven clinical bacterial isolates: Haemophilus influenzae
(11 strains), Klebsiella pneumoniae (13 strains), Pseudo-
monas aeruginosa (10 strains), Staphylococcus aureus
(17 strains), Streptococcus agalactiae (9 strains), Strepto-
coccus pneumoniae (19 strains) and Streptococcus pyo-
genes (2 strains). These clinical strains were obtained
from Microbiology and Immunology Laboratory (EPS
Farhat Hachad, Sousse, Tunisia).
Kirby Bauer paper method
The antibacterial activity of the different essential oils
was evaluated by the paper-disc agar diffusion method
with a bacterial inoculum of 0.5 Mcfarland; Mueller-
Hinton (MH) with 5% sheep blood or with MH only for
Pseudomonas aeruginosa, and Staphylococcus aureus.
Absorbent discs (Whatman disc n°3, 6 mm diameter)
were impregnated with 10 μL of each oil, and then
placed on the surface of inoculated plates (90 mm). Posi-
tive control discs of antibiotics commonly used for the
treatment of respiratory tract diseases were tested. After
24 h of incubation at 37°C, the inhibition zones were
measured and expressed in mm. All experiments were
done in triplicate.
Determination of MIC and MBC
The minimal inhibition concentration (MIC) was studied
only with oils which were proved to effective using the
disc diffusion method (inhibition zones ≥ 17 mm). MIC
was determined using micro-well dilution methodaccording to the protocol of Şahin et al. (2004) [16]. The
96-well plates were prepared by dispensing into each
well 95 μL of nutrient broth and 5 μL of the inoculum.
One-hundred microliters from each extract were initially
prepared at a concentration of 0.166 (v/v) and added
into the first well, followed by two-fold dilution until the
9th well. The wells of column 10 were filled with 195 μL
of MH broth and reserved for the bacterial growth con-
trol, whereas the 11th column wells were reserved for
the control of the broth sterility. The wells of the last
column were used as a negative control, and contained
195 μL of nutrient broth and 5 μL of the inoculum. The
plates were screened visually after incubation at 37°C
for 24 h for broth turbidity. The minimum bactericidal
concentration (MBC) is the lowest concentration of the
essential oil that can kill 99.9% of the bacterial popula-
tion after incubation for 18–24 h at 37°C [17,18]. It was
calculated by inoculating the content of the well indi-




Seven Eucalyptus essential oils were tested against five
fungal strains that comprise one opportunist pathogenic
yeast (Candida albicans), one filamentous (Scopulariop-
sis brevicaulis) and three dermatophytes (Trichophyton
rubrum, Trichophyton soudanense, Microsporum canis).
The micro-organisms were obtained from the Labora-
tory of the Transmissible Diseases and Biological Active
Substances LR99ES27 (Faculty of Pharmacy of Monastir,
Tunisia).
Agar incorporation method
Antifungal activity was carried out by the agar incorpor-
ation method (dilution in a solid medium) including a
negative control, as described previously by Bel Haj
Salah et al. (2006) [19]. The test was performed in sterile
Petri dishes (33 mm) containing Sabouraud Glucose
Agar (SGA). Samples were mixed with ethanol 99% (v/v)
to obtain a final concentration of 1000 μL/mL. This solv-
ent was also used as a negative control. After cooling
and solidification, the medium was inoculated with a
small amount (5 mm) of a 7 day-old mycelium culture
(for dermatophytes), a three days culture suspension
adjusted to 105 conidies/mL (Scopulariopsis brevicaulis)
or a 3 day culture suspended in sterile distilled water
and adjusted to 105 spores/ml (for yeasts). The pevaryl
was used as anti-fungal reference. The Petri dishes were
then incubated for additional seven days at 24°C for
dermatophytes and for the filamentous, 24 h at 37°C
for Candida. Three replications were carried out for
each concentration and for each micro-organism. The
antifungal activity of the essential oils was evaluated by
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diameters of colonies in the control plate (dC) and the
colonies in the treated plate (dE); % I = (dC - dE)/dC,
according to the method of Singh et al. (1993) [20].Cytotoxicity assay
The evaluation of the cytotoxic effect of samples is based
on the reduction of MTT (3-[4,5-dimethylthiazol-2-yl]-
2,5-diphenyl tetrazolium bromide), by the mitochondrial
dehydrogenase of viable cells, to give a blue formazan
product which can be measured spectrophotometrically
at 540 nm. The MTT colorimetric assay was performed
in 96-well plates. Cells were seeded in 96-well plates at a
concentration of 105 cells per well and incubated for
24 h at 37°C in a 5% CO2 humidified atmosphere. After
treatment with various concentrations of the test com-
pound, the cells were incubated for an additional 48 h at
37°C. The cells were examined daily under a phase-
contrast microscope to determine the minimum concen-
tration of compounds that induced alterations in cell
morphology. After that, the medium was removed and
cells in each well were incubated with 100 μL of MTT
solution (5 mg/mL) for 3–4 h at 37°C. Fifty microliters
of dimethyl sulfoxide (DMSO) were then added to dis-
solve insoluble formazan crystal and the plates were
incubated at 37°C for 30 min. Optical density (OD) was
measured at 540 nm using a Perkin-Elmer ELISA reader
(HTS 7000 plus). Data were obtained from duplicate
wells. Cell viability was expressed with respect to the ab-
sorbance of the control wells (untreated cells), which
were considered as 100% of absorbance. The percentage
of cytotoxicity is calculated as [(A - B)/A] x 100, where
A and B are the OD540 of untreated and of treated cells,
respectively. The percentage of viability was carried out
using the formula: 100 - % cytotoxicity. The 50% cyto-
toxic concentration (CC50) was defined as the com-
pound’s concentration (μg/mL) required for the
reduction of cell viability by 50%, which were calculated
by regression analysis [y = f(x); where y =% viability and
x = concentration of extract, μg/mL]. The used definition
of the cytotoxicity, as supported by other reports [21]
was; CC50 < 1.0 μg/mL – high cytotoxicity; CC50 = 1.0-
10.0 μg/mL – moderate; CC50 = 10.0 - 20.0 μg/mL –
mild cytotoxicity; and CC50 > 20 μg/mL – non cytotoxic.Antiviral activity
Cell culture and virus. The Vero cell line was main-
tained in RPMI 1640 (Gibco, Tunisia) supplemented to
fetal bovine serum (10%, v/v), L-Glutamin (2 mM), peni-
cillin (100 U/mL), and streptomycin (100 μg/mL). Cells
were incubated at 37°C in a 5% CO2 humidified atmos-
phere. Coxsakievirus B3 Nancy strain (kindly provided
by Pr. Bruno Pozzetto, Laboratory of Bacteriology-Virology, Saint-Etienne, France) was propagated in Vero
cells.
Confluent Vero cell cultures were treated with three
non cytotoxic concentrations of the essential oil during
and after virus infection in two sets of experiments as
follows: (1) 5 x 104 TCID50 of the virus was exposed to
essential oil for one hr at 37°C. Then 100 μL of the mix-
ture were added to the cells cultured fluently in 96-well
flat-bottom microtiter plate (100 μL); (2) Cells were trea-
ted with essential oil (100 μL) for one hr at 37°C. After
one hr of incubation at 37°C, 5 x 104 TCID50 of the virus
(100 μL) were added.
All plates were incubated at CO2-incubator for 48 hrs.
The viability of the infected and non-infected cells was
evaluated according to the absorbance values of forma-
zan using the MTT inclusion assay, as described in cyto-
toxicity assay. The percentage of protection was
calculated as follows:
Percent protection = [(ODT) - (ODC) V]/[(ODC) M -
(ODC) V] × 100
Where (ODT), (ODC) V and (ODC) M indicate ab-
sorbance of the test sample, the virus-infected control
(no compound) and mock-infected control (no virus and
no compound), respectively. The 50% inhibition concen-
tration (IC50) was calculated by regression curve ana-
lysis, which is defined as the concentration of the
essential oil that inhibits the viral infection by 50% [22].
Statistical analysis
The data were analyzed using analysis of variance
(ANOVA). The significance of the differences between
means was determined at p < 0.05 using Duncan's mul-
tiple range tests. Results were expressed as means ±
Standard Deviation (SD). To evaluate whether the iden-
tified components may be useful in reflecting chemo-
taxonomic and biological activities relationships, 25
compounds detected in the oil samples at an average
concentration greater than 0.9% of the total oil were
selected and used for this purpose. Both of these compo-
nents and all the values of the essential oils zone dia-
meters of bacteria growth inhibition were subjected to a
principal component analysis (PCA) and to hierarchical
cluster analysis (HCA) using SPSS 12.0 software (SPSS
Inc. Chicago, IL, USA). To evaluate the antiviral activity
in vitro, the selectivity index (SI =CC50/IC50) was deter-
mined. The selectivity index describes the ratio between




The chromatographic analysis (GC retention index (RI)
and GC/MS) of the essential oils allowed the identifica-
tion of 144 components representing 87.40 to 99.37% of
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pounds at an average concentration greater than
0.9 ± 0,2% have been retained for the statistical analysis
(Table 1). The main components were 1,8-cineole
(4.5 ± 1,61 -70.4 ± 2.5%) followed by cryptone (0.0 -
20.9 ± 1.3%), α-pinene (1.0 ± 0.7 - 17.6 ± 7.5%), p-cymene
(0.8 ± 0.1 - 16.7 ± 5.2%), α-terpineol (0,6 ± 0,3 - 10,3 ± 1,1%),
trans-pinaocarveol (0.8 ± 0.2 - 7.0 ± 2.5%), phellandral
(0.0 - 6.6 ± 0.4%), cuminal (0.0 - 6.6 ± 0,6%), globulol
(0.6 ± 0.2 - 6.2 ± 0.9%), limonene (0.4 ± 0.2 - 4.4 ± 0.3%),
aromadendrene (0.1 ± 0.0 - 3.6 ± 1.2%), sapthulenol
(0.1 ± 0.1 - 3.2 ± 0.9%) and terpinene-4-ol (0.3 ± 0.1 -
3.0 ± 0.8%).
Principal components analysis (PCA) and hierarchical
cluster analysis (HCA)
The yield content of the 25 selected component was sig-
nificantly different (p<0.05) among species (Table 1).Table 1 Contents (%) of the 25 major compounds of the esse
species, selected for the Principal Components and the Hiera
№ Compounds Abbreviations
E. maidb E. cin
1. α-Pinene α-pin 7.3 ± 0.7 4.5 ± 0.7
2. Limonene lim 3.1 ± 0.2 3.7 ± 0.5
3. 1.8-Cineole 1.8-cin 57.8 ± 1.9 70.4 ± 2.5
4. γ-Terpinene γ-ter 1.7 ± 0.9 0.1 ± 0.0
5. p-Cymene p-cym 7.4 ± 2.9 1.2 ± 0.1
6. Pinocarvone pin 0.5 ± 0.2 0.3 ± 0.1
7. Terpinene-4-ol Ter-4ol 1.1 ± 0.3 0.4 ± 0.1
8. Aromadendrene aro 1.6 ± 0.8 0.1 ± 0.0
9. tr-Pinocarveol tr-pin 2.0 ± 0.8 1.0 ± 0.2
10. Cryptone cry - -
11. α-Terpineol α-ter 2.2 ± 0.2 10.3 ± 1.1
12. Verbenone ver - -
13. Phellandral phe - 0.2 ± 0.2
14. Cuminal cum - 0.1 ± 0.0
15. tr-p-Mentha-1.7. 8dien-2-ol tr-p-men 0.5 ± 0.1 1.0 ± 0.2
16. p-Cymen-8-ol p-cym 0.1 ± 0.0 0.1 ± 0.0
17. cis-p-Mentha-1. 7. 8dien-2-ol cis-men 0.4 ± 0.2 1.0 ± 0.2
18. Caryophyllene oxide car-ox 0.1 ± 0.0 tr ± 0.1
19. Epiglobulol epi 0.4 ± 0.2 0.1 ± 0.1
20. Globulol glo 1.7 ± 1.4 0.6 ± 0.2
21. Viridiflorol vir 0.7 ± 0.3 0.2 ± 0.1
22. Spahulenol spa 0.1 ± 0.1 0.2 ± 0.1
23. Carvacrol car 0.4 ± 0.1 0.1 ± 0.0
24. α-Eudesmol α-eud 1.1 ± 0.6 -
25. β-Eudesmol β-eud 3.0 ± 1.9 0.2 ± 0.0
a Values are means ± SD of triplicate determination.
b E.maid = E. maidenii, E. cin = E. cinerea, E. Sid = E. sideroxylon, E. odo = E. odorata, E.These 25 components were used for the PCA and the
HCA analysis. The PCA horizontal axis explained 47.2% of
the total variance while the vertical axis a further 23.80%
(Figure 1). The HCA based on the Euclidean distance be-
tween groups indicated three specie groups (A, B and C)
(with a dissimilarity of 11.0) (Figure 2), identified by their
essential oil chemotypes. Group A clearly stood out forming
a separate group in the PCA (Figure 1) and a deep dichot-
omy in the HCA (Figure 2). It was correlated positively with
the axes 1 and 2. Groups A and B were negatively corre-
lated, their separation was mainly due to axis 2. Group A
species reduced to E. odorata, the essential oil of which
was characterized by the highest mean percentage of
cryptone (20.9±1.3%), cuminal (6.6±0.6%), phellandral
(6.6±0.4%), verbenone (0.9±0.2%), p-cymen-8-ol
(2.9±0.6%), sapthulenol (3.2±0.9%), carvacrol (1.7±0.3%),
p-cymene (16.7±5.2%), terpinene-4-ol (3.0±0.8%), caryo-
phyllene oxyde (1.7±0.2%), viridiflorol (4.5±1.6%) and byntial oils, extracted from the leaves of 8 Eucalyptus
rchical Clusters Analyses
Contenta (%)
E. sid E. odo E. bic E. leh E. astr E. leuc
6.9 ± 1.1 1.0 ± 0.7 3.7 ± 1.2 17.6 ± 7.5 22.0 ± 6.0 7.8 ± 2.3
4.1 ± 0.1 0.4 ± 0.2 0.9 ± 0.5 4.4 ± 0.3 1.4 ± 0.3 2.0 ± 0.5
69.2 ± 0.6 4.5 ± 1.6 68.0 ± 5.3 56.6 ± 4.3 42.0 ± 5.9 59.2 ± 10.1
0.1 ± 0.0 0.2 ± 0.2 0.1 ± 0.1 0.9 ± 0.2 0.1 ± 0.1 0.2 ± 0.4
0.8 ± 0.1 16.7 ± 5.2 1.4 ± 0.5 2.0 ± 0.2 0.9 ± 0.2 2.9 ± 3.4
0.2 ± 0.0 0.2 ± 0.1 2.2 ± 0.5 0.2 ± 0.0 1.8 ± 0.8 1.2 ± 0.2
0.6 ± 0.0 3.0 ± 0.8 0.2 ± 0.1 0.3 ± 0.1 0.4 ± 0.1 0.2 ± 0.2
0.5 ± 0.2 0.4 ± 0.0 2.0 ± 0.8 0.2 ± 0.0 3.6 ± 1.2 2.1 ± 1.4
1.2 ± 0.1 0.8 ± 0.2 4.6 ± 0.6 1.0 ± 0.2 7.0 ± 2.5 4.3 ± 1.0
tr ± 0.1 20.9 ± 1.3 - - 0.1 ± 0.1 -
5.4 ± 0.9 0.8 ± 0.2 0.6 ± 0.3 8.7 ± 2.5 1.3 ± 0.3 1.6 ± 0.7
tr ± 0.1 0.9 ± 0.2 - - 0.1 ± 0.1 -
- 6.6 ± 0.4 0.2 ± 0.2 - - -
- 6.6 ± 0.6 - - - -
0.6 ± 0.0 0.5 ± 0.1 1.0 ± 0.1 0.2 ± 0.1 0.4 ± 0.1 0.8 ± 0.1
0.1 ± 0.0 2.9 ± 0.6 0.1 ± 0.0 tr ± 0.1 0.1 ± 0.0 0.1 ± 0.1
0.6 ± 0.0 0.1 ± 0.1 1.0 ± 0.1 0.3 ± 0.2 0.4 ± 0.1 0.8 ± 0.1
0.1 ± 0.1 1.7 ± 0.2 tr ± 0.1 0.1 ± 0.1 0.1 ± 0.0 tr ± 0.1
0.1 ± 0.0 tr ± 0.1 1.0 ± 0.2 0.1 ± 0.0 1.2 ± 0.3 1.1 ± 0.6
1.1 ± 0.3 0.8 ± 0.2 5.4 ± 1.2 0.6 ± 0.2 6.2 ± 0.9 5.8 ± 2.9
0.4 ± 0.1 1.0 ± 0.3 0.8 ± 0.2 0.2 ± 0.1 1.1 ± 0.1 0.8 ± 0.4
0.5 ± 0.3 3.2 ± 0.9 0.1 ± 0.0 1.0 ± 0.1 0.9 ± 0.1 0.1 ± 0.1
0.1 ± 0.0 1.7 ± 0.3 0.1 ± 0.0 0.2 ± 0.0 0.2 ± 0.1 0.3 ± 0.3
0.4 ± 0.1 - 0.1 ± 0.0 0.3 ± 0.1 0.1 ± 0.0 0.2 ± 0.1
0.6 ± 0.1 0.1 ± 0.2 tr ± 0.1 0.3 ± 0.1 0.1 ± 0.0 0.1 ± 0.2
bic = E. bicostata, E. leh = E. lehmannii, E. ast = E. astringens, E. leuc = E. leucoxylon.
Figure 1 ACP of the 26 major components of eight eucalyptus essential oils. For the abbreviation of Eucalyptus species (▲) and
components (●) see Table 1.
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of E. maidenii, E. lehmannii, E. sideroxylon and E. cinerea,
has essential oils characterized by the highest amount of
limonene (3.1± 0.2 to 4.4± 0.2%), α-terpineol (2.2 ±0.3%
for E. maidenii to 10.3±1.1% for E. cinerea). The PCA
showed that the variation between these species is mainly
due to the variation of 1,8-cineole content (57.8 ± 1.9% for
E. maidenii to 70.4± 2.5 for E. cinerea) and of α-pinene
(4.5± 0.7% for E. cinerea to 17.6± 7.5% for E. lehmannii).
Group C, consisting of E. astringens, E. leucoxylon and E.
bicostata, has essential oils distinguished by their highest
mean percentage of epiglobulol (1.0 ± 0.2 - 1.2 ± 0.3%), glo-
bulol (5.4 ± 1.2 - 6.2 ± 0.9%), trans-pinocarveol (4.3 ± 1.0 to
7.0 ± 2.5%), aromadendrene (2.0± 0.8 - 3.6 ± 1.2%) and
pinocarvone (1.2± 0.2 - 2.2 ± 0.5%). The E. bicostata
and E. leucoxylon oils differed from E. astringens oil byFigure 2 Dendrogram obtained by hierarchical cluster analysis based
of eight Tunisian Eucalyptus species. Components that characterise thetheir richness in 1,8-cineole (68.0 ± 5.3, 59.2± 10.1%, re-
spectively) and their poverty in α-pinene (3.7± 1.2,
7.8± 2.3%, respectively) against 42.0± 5.9% and 22.0± 6.0%,
respectively for the latter species.
As in the present study, E. cinerea, E. sideroxylon, E.
bicostata, E. maidenii, E. leucoxylon, E. lehmannii and E.
astringens have been reported to contain 1,8-cineole as a
major component [26-30]. It was also reported that E.
cinerea grown in Morocco contained a higher mean per-
centage of 1,8-cineole (87.8%) than that from Tunisia
(70.4-2.5%) [27], whereas E. sideroxylon acclimated in
Tunisia was richer in 1,8-cineole (69.2-0.6%) than that
from Congo (59.9%) [31]. The Tunisian E. astringens es-
sential oil had the same chemotype as that extracted
from leaves picked from Moroccan tree plantations with
an important difference in their mean percentages. Bothon the Euclidean distance between groups of leaf essential oils
major sub groups, considered as chemotypes, are indicated.
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essential oil [32], which was represented by β-caryophyl-
lene (14.75%), p-cymene (17.72%), and α-pinene (12.53%).
The same principal components were also observed in E.
leucoxylon essential oil [33,34], whereas the essential oil
obtained from Iran was significantly richer in 1,8-cineole
(89.8%) than that from Tunisia [33].
Antibacterial activity
The essential oils were tested for their putative antibacterial
activity against seven bacterial isolates represented by 81
strains (Table 2). As shown in Table 2, E. odorata oil pos-
sessed the best activity against S. aureus (27.4±10.7 mm,
zdi), followed by S. agalactiae (19.4±5.6 mm, zdi), H. influ-
enzae (19.2± 9.6 mm, zdi), S. pyogenes (19.0± 0.0 mm, zdi)
and S. pneumoniae (17.4±4.1 mm, zdi). E. maidenii oil showed
a relatively good activity against S. aureus (22.8±6.8 mm, zdi).Table 2 Diameter of the inhibition of respiratory bacterial gro







E. maidenii 14.5 ± 5.7bc•) 10.7 ± 1.5ab 7.1 ± 1.5
E. odorata 19.2 ± 9.6b 10.8 ± 1.2a 6.0 ± 0.0
E. lehamnnii 11.5 ± 3.3bc 6.8 ± 0.7a 6.5 ± 0.8
E. leucoxylon 8.1 ± 2.2a 6.6 ± 1.1a 6.0 ± 0.0
E. bicostata 13.6 ± 5.0b 7.1 ± 1.4a 6.0 ± 0.0
E. astringens 13.0 ± 3.8bc 7.1 ± 1.6a 6.0 ± 0.0
E. cinerea 13.0 ± 6.3b 8.5 ± 2.2a 6.2 ± 0.6
E. sideroxylon 12.3 ± 8.4b 8.1 ± 1.8a 7.0 ± 1.5
Reference antibiotics




Ceftazidime NT 22.3 ± 7.5a 23.8 ± 5.6
Cehotaxime 20.7 ± 6.0b NT NT
Ciprofloxacin NT 32.4 ± 2.9b 34.7 ± 5.0
Erythromycin 19.9 ± 4.2b NT NT
Fosfomycin NT 22.1 ± 2.9a NT
Gentamicin NT 22.9 ± 5.0a NT
Imipenem NT NT 24.6 ± 6.6
Levofloxacin NT NT NT
Lincomycin 11.3 ± 1.8a NT NT
Oxacillin NT NT NT
Piperacillin NT NT 25.3 ± 7.3
Rifamycin 23.9 ± 4.7b NT NT
Tetracyclin 29.2 ± 2.6c NT 24.4 ± 6.1
Vancomycin NT NT Nt
*Values are means (mm. ±SD) of triplicate determination.
•) Values with different letters differ significantly by Duncan's multiple range test (p
NT=Not tested.To evaluate the correlation between the antibacterial
activities and the essential oils of the eight Eucalyptus spe-
cies, all the mean values of the zone diameters inhibition
were subject to the PCA and the HCA analysis. The statis-
tical analysis of the antibacterial activities of the oils
showed a significant difference among Eucalyptus species
oils and the tested bacterial strains (p < 0.05). The PCA
horizontal axis explained 59.39% of the total variance,
while the vertical axis a further 13.84% (Figure 3). The
HCA showed two species groups (I and II), identified by
their bacteria growth inhibition with a dissimilarity≥ 15.0
(Figure 4). When the dissimilarity was≥ 5.0, group II was
divided into three subgroups (IIa, IIb and IIc). The hori-
zontal axis permitted the separation of group I from group
II, however axis II separated all the species of the group II
into three subgroups. Group I, limited to the Gram nega-
tive (Gram(−)) bacteria, P. aeruginosa and K. pneumoniae,wth by essential oils and by antibiotics*)









a 22.8 ± 6.8d 13.8 ± 2.2bc 13.0 ± 2.6bc 15.5 ± 4.0c
a 27.4 ± 10.7c 19.4 ± 5.6b 17.4 ± 4.1b 19.0 ± 0.0b
a 14.2 ± 4.8c 11.1 ± 1.4b 9.8 ± 2.4b 11.5 ± 1.7bc
a 16.4 ± 5.4c 12.9 ± 1.8b 14.4 ± 3.0bc 9.0 ± 0.0a
a 15.6 ± 2.8bc 13.8 ± 2.8b 17.0 ± 4.0c 13.0 ± 0.0b
a 15.5 ± 5.2c 12.0 ± 3.2b 12.3 ± 12.3bc 12.5 ± 1.7bc
a 12.2 ± 2.8b 11.6 ± 1.4b 11.5 ± 2.8b 12.5 ± 1.7b
a 13.7 ± 3.8b 12.3 ± 1.6b 10.7 ± 2.5ab 12.0 ± 0.0b
NT NT NT NT
24.5 ± 7.5a NT NT NT
a NT NT NT NT
NT NT NT NT
b NT NT NT Nt
29.9 ± 5.1ab 29.2 ± 4.2b 26.3 ± 12.0a 29.0 ± 0.0c
34.3 ± 11.1c 27.9 ± 5.9ab 35.6 ± 5.5c 24.5 ± 0.8a
29.6 ± 6.2ab NT NT NT
a NT NT NT NT
NT 24.8 ± 2.8a 27.3 ± 3.5ab 25.0 ± 1.5ab
NT NT NT NT
NT 33.6 ± 4.2c 31.7 ± 11.9abc 30.0 ± 0.0c
a NT NT NT NT
NT 34.4 ± 4.3c 37.5 ± 8.1c 31.5 ± 0.8d
a NT NT NT NT
25.3 ± 4.4a 26.3 ± 3.4ab 33.0 ± 3.5bc 26.0 ± 2.0 b
< 0.05).
Figure 3 PCA of the antibacterial activity of 08 Eucalyptus essential oils species against seven clinical bacteria (■). For the abbreviation
of the Eucalyptus species (▲) see Table 1.■) Hem inf = Haemophylis influenza, kle = Klebsiella pneumoniae = Pse aer: Pseudomans aeruginosa, sta
aur = Staphylococcus aureus, Stre B = Streptococcus agalactiae, Stre pneu = Streptococcus pneumoniae, Strep pyo = Streptococcus pyogenes.
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clearly separated group in the PCA analysis. These two
strains were the most resistant to the majority of Eucalyptus
essential oils with zdi < 7.1 mm for P. aeruginosa and
10.7± 1.5 mm for K. pneumoniae. Compared to the
growth inhibition zone produced by ciprofloxacin against
P. aeruginosa (34.7±5.0 mm, zdi) and K. pneumoniae
(32.4±2.9 mm, zdi). Subgroup Ia was limited to S. aureus
which was characterized by the highest sensitivity to E. mai-
denii and E. odorata oils (22.8±6.8 and 27.4±10.7 mm,
zdi, respectively). This high sensitivity could be due to the
disposition of E. maidenii and E. odorata oils with a rela-
tively high mean percentage of the monoterpene hydrocar-
bons p-cymene (7.4±2.9, 16.7±5.2%, respectively).
Previous studies have reported the high sensitive character
of S. aureus to essential oils with a high content ofFigure 4 Dendrogram obtained by hierarchical cluster analysis based
activities of leaf essential oils of eight Tunisian Eucalyptus species. Fop-cymene [35]. In addition, other researchers reported that
this sensitivity of S. aureus was due to the single layer wall
of the bacteria [36]. Comparing these results with those
obtained with antibiotics, E. odorata essential oil produced
a similar inhibition to that produced by gentamicin,
erythromycin, vancomycin and benzylpenicillin (29.6± 6.2,
29.9± 5.1, 25.3±4.4 and 24.5± 7.5 mm, dzi, respectively).
However, this activity remained lower than that produced
by fosfomycin (34.3±11.1 mm, dzi). Sub group IIb repre-
sented by S. pneumoniae, showed a particular sensitivity to
E. odorata and E. bicostata essential oils (17.4± 4.1 and
17.0± 4.0 mm, zdi). This inhibition remained lower than
that produced by its specific antibiotics with zone dia-
meters inhibition ranging from 26.3±12.0 mm (erythro-
mycin) to 35.6±5.5 mm (fosfomycin). E. lehmannii, E.
sideroxylon and E. cinerea oils did not show significanton the Euclidean distance between groups of the antibacterial
r the abbreviation of the Eucalyptus species (▲), see Table 1.
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10.7± 2.5 and 11.5±2.8 mm, respectively. Subgroup IIc,
consists of Streptococcus B, S. pyogenes and H. influenzae.
These strains were separated from all the others and cor-
related positively with the two axes and with E. cinerea
and E. sideroxylon, the essential oils of which were charac-
terized by a comparable activity against the previous bacter-
ial strains, with inhibition zone diameters varying from
11.6±1.4 mm to 13.0± 6.3 mm. Their activities were con-
sidered relatively as being lower than the tested antibiotics
such as rifamicine and ampicilline. However E. odorata oil,
which was removed from this group, showed the best ac-
tivity against these bacterial strains with inhibition zone
diameters varying from 17.4± 4.1 mm for S. pneumoniae
to 19.4 ± 5.6 for Streptococcus B, but it remained much
lower than that produced by their specific antibiotics. The
MIC was performed for oils which have produced an in-
hibition ≥ 17 mm for clinical bacterial strains such as H.
influenzae (reference 160), S. agalactiae (reference 3) S.
pyogenes (reference 545) and S. aureus (reference 278).
The result of their MIC was listed in Table 3. E. odorata
and E. bicostata oils were characterized by the lowest MIC
for Hemophylis influenzae (reference 160) (0.306 mg/mL),
followed by S. agalactiae (reference 3) (10.4 mg/mL). These
results were confirmed by the disc diffusion method. The
highest MIC against S. aureus (reference 278) was shown
for the oils of E. bicostata (169 mg/mL), E. odorata
(156.6 mg/mL) and E. maidenii (151.8 mg/mL). This find-
ing was in contradiction to results obtained by the disc dif-
fusion method. According to the classification of
Schaechter et al. (1999) [37] and Soro et al. (2010) [38], E.
odorata, E. bicosta and E. maidenii oils were considered
bactericidal (MBC/MIC<4) against the tested strains, how-
ever the two first oils showed a better bactericidal activity
against H. influenzae (reference 160) and S. aureus (refer-
ence 278) than that obtained with S. pyogens (reference
545) and S. aglatctiae (reference 3).Table 3 Minimal Inhibition concentration (MIC), minimal bact
most effective oils against respiratory microorganisms
Essential oils
H.inf160 a)
E. odorata MIC 0.306b)
MBC 0.306
MBC/MIC 1
E. bicostata MIC 0.331
MBC 0.331
MBC/MIC 1
E. maidenii MIC NT
MBC NT
MBC/MIC NT
a): H. inf 160=Hemophylus influenza (160); Strep B3 = Streptococus B3= Streptococcus
b): values were expressed as mg/ml; NT =Not tested.Antifungal activity
Seven Eucalyptus oils were tested for their antifungal
and anti-yeast activities. The result of their average per-
centages inhibition was listed in Table 4. Their variance
analysis showed a highly significant effect for all oils
(p < 0.05), except for E. odorata and E. cinerea oils
(p > 0.05).
The PCA horizontal axis explained 73% of the total vari-
ance, while the vertical axis a further 14.15% (Figure 5).
The HCA indicated three groups of species (A, B and C)
with a dissimilarity≥ 5.0 (Figure 6).
Group A, limited to Scopulariopsis brevicaulis, corre-
lated negatively with axis 1 and with the group C. This
species was distinguishable in the PCA and formed a
distinct group. It was considered as being the most resist-
ant to all the tested oils. Group B was formed by Tricho-
phyton soudanense (correlating positively and negatively
with axis 1 and 2, respectively) and by Trichophyton
rubrum (correlating negatively with the two axes). These
strains were distinguished by their highest sensitivity to
E. odorata oil (100% of inhibition); however, the variabil-
ity between these two fungi strains was mainly due to the
higher sensitivity of Trichophyton soudanense to E. leh-
mannii and E. maidenii oils than that of Trichophyton
rubrum and also to the resistance of Trichophyton souda-
nense to E. cinerea oil. Group C, which was formed by
the yeast Candida albicans and by the fungi Micro-
sporum canis, correlated positively with the two axes and
was characterized by a relatively high sensitivity to E.
bicostata, E. astringens and E. sideroxylon; however, these
strains showed a higher resistance to the other oils.
According to the chemical composition of these essen-
tial oils, the antifungal activity was not related to the
high content of one chemical compound, rather than to
synergic effects between major and minor components.
For example, 1,8-cineole, which was discussed above as
the principal component of the most essential oils, didericidal concentration (MBC) and ratio MBC/MIC of the
Tested microorganisms










agalactiae3; S.pyo545 = Streptoccus pyogenes; S.aur278 = Staphylococcus aureus.
Table 4 Antifungal activity of seven Eucalyptus essential oils*)
Essential oils Tested microrganisms
Trichophyton rubrum Trichophyton soudanense Microsporum canis Scopulariopsis brevicaulis Candida albicans
E. maidenii 31.9 ± 2.1a•) 66.8 ± 17.1b 53.9 ± 0.0b 22.8 ± 2.1a 60.0 ± 0.0b
E. odorata 100.0 ± 0.0b 100.0 ± 0.0b 100.0 ± 0.0e 69.7 ± 0.0a 100.0 ± 0.0b
E. sideroxylon 30.4 ± 0.0bc 29.0 ± 6.4b 68.1 ± 5.1d 12.2 ± 4.3a 40.0 ± 0.0c
E. bicostata 28.9 ± 2.1a 23.0 ± 6.4a 59.2 ± 2.5b 28.9 ± 2.1a 80.0 ± 0.0c
E. astringence 37.9 ± 2.1b 38.1 ± 2.1b 61.0 ± 0.0c 22.8 ± 10.7a 60.0 ± 0.0c
E. lehmannii 27.3 ± 0.0b 39.6 ± 4.3c 34.3 ± 2.5c 0.1 ± 0.0a 40.0 ± 0.0c
E. cinerea 24.3 ± 0.0ab 41.1 ± 15.0cd 55.6 ± 12.6d 4.6 ± 6.4a 40.0 ± 0.0cd
Pevaryl (std) 100.0 ± 0.0a 100.0 ± 0.0a 100.0 ± 0.0a 100.0 ± 0.0a 100.0 ± 0.0a
*) Values were expressed as a percentage of inhibition ± SD at the concentration 1000 ppm of triplicate determination.
•) Values with different letters differ significantly by Duncan's multiple range test (p< 0.05) std: standard for antifungal activity. E.: Eucalyptus.
Elaissi et al. BMC Complementary and Alternative Medicine 2012, 12:81 Page 10 of 15
http://www.biomedcentral.com/1472-6882/12/81not correlate with the high antifungal activity because E.
cinerea (70.4 ± 2.5%), E. leucoxylon (59.2 ± 10.1%), E. leh-
manii (56.6 ± 4.3%), and E. maidenii (57.8 ± 1.9%)
showed a lower antifungal activity than E. bicostata, E.
astringens and E. sideroxylon. Additionally, the essential
oils of E. bicostata, E. astringens, characterized by the
highest content of pinocarvone (2.2 ± 0.5 and 1.8 ± 0.8%,
respectively), tr-pinocarveol (4.6 ± 0.6 and 7.0 ± 2.5%, re-
spectively) and globulol (5.4 ± 1.2 and 6.2 ± 0.9%, respect-
ively), showed a lesser antifungal activity than the
essential oil of E. sideroxylon.Figure 5 PCA of the antifungal activity of 08 Eucalyptus essential oils
T. sou= Trichophyton soudanense, M. can=Microsporum canis; S. bre =
abbreviation of the Eucalyptus species (▲) (see Table 1).Cytotoxicity assay
The cytotoxicity effect of the eight Eucalyptus essential
oils on Vero cell lines varied significantly within species
(Table 5). Vero cells were resistant to the essential oils
of E. maidenii, E. sideroxylon and E. cinerea with CC50
values of 253.5, 247.3 and 204.5 mg/mL, respectively.
The essential oils of E. odorata, E. leucoxylon, E. leh-
mannii, E. astringens and E. bicostata demonstrated a
different behavior and their cytotoxicity increased con-
siderably with CC50 varying from 6.2 to 16 mg/mL. We
did not notice any clear correlation between thespecies against five fungi (♦): T. rub= Trichophyton rubrum,
Scopulariopsis brevicaulis, C. alb = Candida albicans. For the
Figure 6 Dendrogram obtained by hierarchical cluster analysis based on the Euclidean distance between groups of the antifungal
activities of leaf essential oils of seven Tunisian Eucalyptus species. For the abbreviation of the fungi strains, see Figure 5.
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http://www.biomedcentral.com/1472-6882/12/81chemical composition of the tested oils with the results of
the cytotoxic effect and further investigation needs to be
undertaken. However, the lowest cytotoxicity was
observed with oils having a high content of 1,8-cineole
but with a moderate amount of α-pinene and limonene
such as those of E. maidenii, E. sideroxylon and E. cinerea.




*) (mg/mL, ± SD) Concentrations
(mg/mL) Pre-treatment of cell
E. cin 204.5 ± 0.35b•) 150 66.5
75 0
37.5 0
E. sid 247.3 ± 0.9c 150 0
75 0
37.5 0
E. mai 253.5 ± 0.35c 150 29
75 0
37.5 0
E. leh 15 ± 00.0a 15 0
7.5 0
3.75 0
E. bic 16 ± 00.0a 15 0
7.5 66.5
3.75 37.5
E. ast 15.7 ± 0.14a 15 0
7.5 0
3.75 0
E. leu 14.9 ± 0.07a 15 0
7.5 0
3.75 0
E. odo 6.2 ± 0.14a 6 0
3 0
1.5 0
*) Values were expressed as a cytotoxic concentration ± SD of duplicate determinati
•) Values with different letters differ significantly by Duncan's multiple range test (p
Nd: Not determined.astringens oils, which were characterized by a higher mean
percentage of the monoterpene α-pinene and by a moder-
ate mean percentage of 1,8-cineole. The present result
was confirmed by Setzer et al. (2006) [39], who demon-
strated that the monoterpene hydrocarbons α-pinene had
a stronger cytotoxicity activity against Hs 578 T and Hep-
G2 cell lines than 1,8-cineole. It was also observed that alyptus essential oils
Antiviral activity
s IC50 (mg/ml) SI Pre-treatment of virus IC50 (mg/ml) SI
131b 1.56a 71 102c 2a
54
0
Nd Nd 0 Nd Nd
0
0
233.5c 1.08a 62.5 136.5d 1.85a
0
0
Nd Nd 0 Nd Nd
0
0
4.8a 3.33b 0 0.7a 22.8b
87.5
83
Nd Nd 83 8.4b 1.86a
46
25
Nd Nd 0 Nd Nd
0
0
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bulol and viridiflorol and the monterpene hydrocarbons
α-pinene of E. astringens, E. lehmannii and E. leucoxylon
oils could make the cell lines more sensitive. On the other
hand, the significant high cytotoxicity of E. odorata oil
could be explained by the latter’s lack of 1,8-cineole and
its richness in the ketone cryptone, the monoterpene
hydrocarbons p-cymene and in theses aldehydes: phellan-
dral and cuminal [40]. This cytotoxicity effect could be
due to the synergetic effect of the previous main consti-
tuents of this essential oil. Compared to the previous
studies, the cytotoxicity of our studied essential oils was
very low CC50 > 20 μg/mL [21]. Therefore they could
be considered as being safe for use at non cytotoxic
concentrations.
Antiviral activity
In order to elucidate the mode of antiviral action and to
identify the target site, cells were pre-treated with essen-
tial oils before viral infection (pre-treatment of cells) and
the virus was incubated with essential oils before cell in-
oculation (pre-treatment of virus). All samples tested
were used at their maximum non-cytotoxic concentra-
tions (Table 5). The essential oils of E. sideroxylon, E.
lehmannii, E. leucoxylon and E. odorata showed no in-
hibition of viral infection, whereas the most significant
antiviral activity was shown with the essential oils of E.
bicostata (IC50 = 0.7 - 4.8 mg/mL) and E. astringens
(IC50 = 8.4 mg/mL), followed by essential oils of E.
cinerea (IC50 = 102–131 mg/ml) and E. maidennii (IC50 =
136.5 - 233.5 mg/mL). The selectivity index describes
the ratio between the cytotoxic and the antiviral activity
of a tested sample. The virus pretreatment with E. bicos-
tata essential oil showed a better antiviral activity
(IC50 = 0.7 mg/mL, SI = 22.8) than cell-pretreatment
(IC50 = 4.8 mg/mL, SI = 3.33). The essential oil of E.
astringens showed an antiviral activity only when incu-
bated with a virus prior to cell infection. This activity
was dose-dependent and the antiviral activity decreased
with the diminishing essential oil concentration. E.
cinerea and E. maidenii essential oils showed an antiviral
activity at a concentration of 150 mg/mL when incu-
bated with cells. This activity increased significantly at
the same concentration when the sample was incubated
with a virus prior to infection.
According to these results, no correlation was found
between the chemical composition and the antiviral
assay. Therefore the activity of the tested essential oils
could be due to a synergism between the major and
the minor components. Altogether, the essential oils
used in the present study exhibited the best antiviral
effect when incubated with a virus. From the pre-
sented results, E. odorata oil was associated with E.
maidenii, E. bicostata, E. lehamnnii, E. astringens andE. leucoxylon oils in both the antibacterial PCA and
HCA. However, it remained associated with E. maide-
nii and E. lehmannii in the antifungal PCA analysis.
Therefore, the biological activity has allowed the asso-
ciation of different chemotypes in the same group
producing a similar biological activity. This allowed us
to deduce that the global biological activity of these
oils was mainly due to an addition or a synergism ef-
fect between the major and the minor components.
This was confirmed by Paster et al. (1995) [41]. The
best activity was recorded with E. odorata oil against
the majority of the microbial strains with inhibition
zone diameters almost equal to those produced by
erythromycin against clinical strains H. inflenzae, S.
aureus, and to the Pevaryl against the three dermato-
phytes fungi and the Candida albicans. This property
could be explained by the richness of E. odorata oil in
p-cymene (16.7 ± 5.2%), terpinene-4-ol (3.0 ± 0.8%),
spathulenol (3.2 ± 0.9%), carvacrol (1.7 ± 0.3%), caryo-
phyllene oxide (1.7 ± 0.2%), p-cymene-8-ol (2.9 ± 0.6%),
verbenone (0.9± 0.2%), viridiflorol (1.0 ± 0.3%), phellandral
(6.6 ± 0.4%), cuminal (6.6 ± 0.6%) and cryptone (20.9 ±
1.3%), and by its poverty in 1,8-cineole (4.5 ± 1.6%). It
appeared that all the strains were resistant to oils rich in
the latter component which varied from 42.0± 5.9% for E.
astringens to 70.4± 2.5% for E. cinerea. On the other hand,
oils characterized by a small quantity of 1,8-cineole and by
a medium mean percentage of the monoterpene, p-cym-
ene, the ketone, cryptone, the aldehydes, phellandral and
cuminal were more active. These results were confirmed
by Mulyaningsih et al. (2010) [42], who demonstrated that
the antimicrobial activity of pure 1,8-cineole was inferior
to the totality of E. globulus fruit oil, considered poor in
the latter component and rich in aromadendrene and glo-
bulol. Dorman and Deans (2000), also confirmed that the
antimicrobial activity increased with oils rich in aldehydes,
ketones and phenols [43]. E. maidenii oil was character-
ized by a relatively high mean percentage of 1,8-cineole
(57.8 ± 1.9%), p-cymene (7.4± 2.9%), α-pinene (7.3± 0.7%),
limonene (3.1± 0.2%), α-terpineol (2.2 ± 0.2%), the activity
of which occupied the second position after E. odorata oil
against all the bacterial strains (7.1 ± 1.5 mm, zdi, for P.
aeruginosa to 22.8± 6.8 mm, zdi, for S. aureus) and also
against the fungal strains with an inhibition percentage
varying from 22.8± 2.1% for Scopulariopsis brevicaulis to
66.8± 17.1% for Trichophyton soudanense. However, oils
of E. sideroxylon and E. cinerea, which were distinguished
by the highest levels in 1,8-cineole, were less active against
the tested microorganisms than the majority of the
remaining oils. The present finding was in contradiction
with previous studies reporting that 1,8-cineole had strong
antimicrobial properties against many important patho-
gens [44,45]. It seems that the activity of this chemical
compound was inhibited by other minor components.
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understand the present issue.
According to the study of Claudio et al. (2008), the es-
sential oil of E. globulus has shown a higher antibacterial
activity against Haemophilus influenzae (28 mm, zdi)
than the tested essential oils in the present study,
whereas it possessed comparative inhibition activities
against S. pneumoniae (15 mm vs 9.8-17.4 mm, zdi).
However, our essential oils exhibited a better activity
against K. pneumoniae (6.6-10.7 mm vs 0 mm, zdi), S.
aureus (12.2-27.4 mm vs 2 mm, zdi), S. agalactiae (11.1-
19.4 mm vs 3 mm, zdi) and S. pyogenes (9–19 mm vs
5 mm, zdi) [46]. Martin et al. (2010) have reported simi-
lar findings concerning the antibacterial activity of the
essential oils of E. dives and E. staigeriana against
Pseudomonas aeruginosa (7.7-9.1 mm vs 6–7.1 mm, zdi)
[47].
We also noticed that Microsporum canis is more sensi-
tive to E. sideroxylon oil than that of E. cinerea. This
sensitivity could be attributed to the presence of a higher
content of α-pinene and limonene and a lower percent-
age of α-terpineol in E. sideroxylon oil. The comparative
study of the antibacterial activity result of the tested oils
obtained by the disc diffusion method with the results
obtained by micro-well dilution showed for some species
a concordance of the two methods and discordance for
others, especially against the Gram positive (Gram (+)),
S. aureus (278). Compared to the activities produced by
the tested antibiotics, all the essential oils were less ac-
tive. An association of the most active oils together may
moderate the activity against the most resistant strains.
Conclusions
In conclusion, our study showed that the chemical PCA
and HCA analysis separated all the species oils into
three groups, each group constituted a chemotype; how-
ever, in the PCA and HCA analysis of the antibacterial
activity, five groups and sub groups of bacterial strains
were identified and separated by their sensitivity levels
to the tested essential oils. E. cinerea of the group B was
the richest species in 1,8-cineol. However, E. odorata oil
of the group A was the richest in cryptone. The Eucalyp-
tus essential oils activity varied significantly within spe-
cies and within strains. In general, the strong
antimicrobial activity was not related only to a high con-
tent of one major component such as 1,8-cineole, but
also to the presence of moderate and minor compounds.
The Gram (−) bacteria P. aeruginosa and K. pneumoniae
were the most resistant to all the oils but more sensitive
to the antibiotics, ciprofloxacin and ampicillin. Com-
pared to antibiotics and antifungal fosfomycin, ampicil-
lin, rifamycin and pevaryl, the clinical strains S. aureus,
H. influenzae, S. agalactiae, S. pyogenes, S.pneumoniae
and all the tested fungal strains were more sensitive toE. odorata oil. Taking into account all these results, E.
odorata oil provide a promising product in the thera-
peutic application for the treatment of some respiratory
bacterial infections and fungal diseases. The cytotoxicity
of the tested oils on Vero cell lines varied significantly
within species. E. odorata oil which was the richest spe-
cies in the ketone cryptone, had the highest cytoxicity,
whereas E. maidenii, E. sideroxylon and E. cinerea oils,
which were characterized by the highest mean percent-
age of 1,8-cineole and by a moderate amount of α-pi-
nene, were less toxic. E. bicostata oil had the best
antiviral activity against coxsakievirus B3 whenever incu-
bated with the Vero cell lines or with the virus. This es-
sential oil may serve as a potential candidate against
enterovirus infections. Further analyses need to be
undertaken to test this essential oil on other viruses
belonging to the genus enterovirus. However, E. astrin-
gens oil exhibited a significant antiviral activity only
when incubated with the virus. This shows that this es-
sential oil had a direct effect on the coxsakievirus B3.
We could not elucidate the mode of action of these es-
sential oils and their interactions with both cells and the
virus remains to be elucidated.
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